MetaCap

Q/C Technologies Insider Trades

NASDAQ: QCLSHealth CareBiotechnology: In Vitro & In Vivo Diagnostic SubstancesUSD

0.2784-0.0178 (-6.01%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
1 · $5.52K
Sales
0 · $0
Shares bought / sold
1.75K / 0
Net activity
Net buying $5,522

Q/C Technologies insider activity

Over the last 12 months, Q/C Technologies insiders reported 8 transactions on SEC Form 4: 1 open-market purchase and 0 sales. Insiders bought $5,522 and sold $0 worth of stock, for net insider buying of $5,522. The most recent filing shows PharmaCyte Biotech, Inc. (10% Owner) reporting a transaction in 4,982,272 shares on Nov 18, 2026.

Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put QCLS's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

QCLS insider transactions

Q/C Technologies insider transactions
DateInsiderTypeSharesValueFiling
Nov 18, 2026PharmaCyte Biotech, Inc.10% OwnerOption exercise4,982,272—Form 4
Oct 1, 2026Silverman JoshuaExecutive ChairmanAward77,390—Form 4
Jul 10, 2026Silverman JoshuaExecutive ChairmanAward16,620—Form 4
Apr 13, 2026Silverman JoshuaExecutive ChairmanAward162,162—Form 4
Apr 13, 2026Silverman JoshuaExecutive ChairmanAward16,806—Form 4
Mar 30, 2026Voss Chelsea SierraDirectorBuy1,753$5.52KForm 4
Jan 16, 2026Voss Chelsea SierraDirectorAward25,000—Form 4
Jan 16, 2026Voss Chelsea SierraDirectorAward212,500—Form 4
Nov 14, 2025RAUCH GARY MVice President of FinanceAward11,420—Form 4
Nov 14, 2025Silverman JoshuaExecutive ChairmanAward91,356—Form 4
Nov 14, 2025Bernstein BruceDirectorAward25,000—Form 4
Nov 14, 2025Friscia StephenDirectorAward22,839—Form 4
Nov 14, 2025Glass MitchellDirector, Chief Medical Off.Award11,420—Form 4
Nov 14, 2025White Billy JoeDirectorAward22,839—Form 4
Oct 3, 2025White Billy JoeDirectorAward2,161—Form 4
Oct 3, 2025Glass MitchellDirector, Chief Medical Off.Award1,080—Form 4
Oct 3, 2025RAUCH GARY MVice President of FinanceAward1,080—Form 4
Oct 3, 2025Friscia StephenDirectorAward2,161—Form 4
Oct 3, 2025Silverman JoshuaExecutive ChairmanAward8,644—Form 4
Aug 24, 2023Rivard PaulChief Legal OfficerBuy150,000$166.50KForm 4
Aug 17, 2023Rivard PaulChief Legal OfficerBuy25,000$28.08KForm 4
Dec 8, 2022Rivard PaulEVP of Operations, GCBuy10,000$15.30KForm 4
Nov 26, 2021Silverman JoshuaDirectorBuy5,000$37.77KForm 4
Nov 24, 2021Silverman JoshuaDirectorBuy3,266$23.17KForm 4
Nov 24, 2021Silverman JoshuaDirectorBuy6,734$42.42KForm 4
Nov 23, 2021Rivard PaulEVP of Operations, GCBuy15,000$90.45KForm 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related